Roivant Sciences Ltd
ROIV
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.36B
Close$
$1.85
94.9% downside
Current Fair Value
94.9% downsideOvervalued by 94.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.36 Billion |
|---|---|
| Enterprise Value | $25.29 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 1.1 |
| Outstanding Shares | 720,776,739 |
Return
| Return on Equity | -6.29% |
|---|---|
| Return on Assets | -5.02% |
| Return on Invested Capital | -22.85% |
Valuation & Multiples
| P/E Ratio | -96.03 |
|---|---|
| PEG | 639.78 |
| Price to Sales | - |
| Price to Book Ratio | 6.08 |
| Enterprise Value to Revenue | 3357.73 |
| Enterprise Value to EBIT | -22.03 |
| Enterprise Value to Net Income | -95 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.07 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
$3.74 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 105.62% |
|---|---|
| Total Calls | 2,244,400▼ 77.20% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.22%▼ 75.55% |
|---|---|
| Total Invested | $584.29M▼ 97.06% |
| Investors Holding | 50▼ 468.00% |
ESG Score
No data